AAAAAA

   
Results: 1-10 |
Results: 10
Characterization of tubular functional capacity in humans using para-aminohippurate and famotidine
Authors: Dowling, TC Frye, RF Fraley, DS Matzke, GR
Citation: Tc. Dowling et al., Characterization of tubular functional capacity in humans using para-aminohippurate and famotidine, KIDNEY INT, 59(1), 2001, pp. 295-303
Unintended immunomodulation: Part I. Effects of common clinical conditionson cytokine biosynthesis
Authors: ALKarfy, KM Kellum, JA Matzke, GR
Citation: Km. Alkarfy et al., Unintended immunomodulation: Part I. Effects of common clinical conditionson cytokine biosynthesis, SHOCK, 13(5), 2000, pp. 333-345
Unintended immunomodulation: Part II. Effects of pharmacological agents oncytokine activity
Authors: ALKharfy, KM Kellum, JA Matzke, GR
Citation: Km. Alkharfy et al., Unintended immunomodulation: Part II. Effects of pharmacological agents oncytokine activity, SHOCK, 13(5), 2000, pp. 346-360
Nephrology pharmaceutical care preceptorship: A programmatic and clinical outcomes assessment
Authors: Matzke, GR St Peter, WL Comstock, TJ Foote, EF
Citation: Gr. Matzke et al., Nephrology pharmaceutical care preceptorship: A programmatic and clinical outcomes assessment, ANN PHARMAC, 34(5), 2000, pp. 593-599
Determinants of ceftriaxone clearance by continuous venovenous hemofiltration and hemodialysis
Authors: Matzke, GR Frye, RF Joy, MS Palevsky, PM
Citation: Gr. Matzke et al., Determinants of ceftriaxone clearance by continuous venovenous hemofiltration and hemodialysis, PHARMACOTHE, 20(6), 2000, pp. 635-643
Evaluation of the influence of diabetes mellitus on antipyrine metabolism and CYP1A2 and CYP2D6 activity
Authors: Matzke, GR Frye, RF Early, JJ Straka, RJ Carson, SW
Citation: Gr. Matzke et al., Evaluation of the influence of diabetes mellitus on antipyrine metabolism and CYP1A2 and CYP2D6 activity, PHARMACOTHE, 20(2), 2000, pp. 182-190
Determinants of ceftazidime clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis
Authors: Matzke, GR Frye, RF Joy, MS Palevsky, PM
Citation: Gr. Matzke et al., Determinants of ceftazidime clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis, ANTIM AG CH, 44(6), 2000, pp. 1639-1644
Effect of ceftazidime on systemic cytokine concentrations in rats
Authors: Alkharfy, KM Kellum, JA Frye, RF Matzke, GR
Citation: Km. Alkharfy et al., Effect of ceftazidime on systemic cytokine concentrations in rats, ANTIM AG CH, 44(11), 2000, pp. 3217-3219
Comparison of iothalamate clearance methods for measuring GFR
Authors: Dowling, TC Frye, RF Fraley, DS Matzke, GR
Citation: Tc. Dowling et al., Comparison of iothalamate clearance methods for measuring GFR, PHARMACOTHE, 19(8), 1999, pp. 943-950
Intravenous iron supplementation in end-stage renal disease patients
Authors: Matzke, GR
Citation: Gr. Matzke, Intravenous iron supplementation in end-stage renal disease patients, AM J KIDNEY, 33(3), 1999, pp. 595-597
Risultati: 1-10 |